2010 Q3/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +0 Neurimmune Therapeutics AG
9.0
2 +1 Newron
8.2
3 +1 Medinova AG
7.8
4 +1 AmVac AG
7.4
5 +2 OMIDA AG
6.9
6 +7 Alpex Pharma SA
6.9
7 +2 Johnson & Johnson Pharmaceutical Research & Development
6.8
8 -2 ArisGen SA
6.7
9 +2 F. Hoffmann-La Roche AG Global
6.7
10 +2 4-Antibody AG
6.7
11 -3 Arpida AG
6.6
12 +3 Evolva SA
6.6
13 +3 Axenoll AG
6.5
14 +0 Antares Pharma AG
6.5
15 +4 Neurotune
6.4
16 -6 BioPartners GmbH
6.3
17 +3 Tricom GmbH, Pharma Division
6.3
18 -1 Siegfried AG
6.3
19 +5 Nycomed International Management GmbH
6.2
20 -2 Kuros Biosurgery AG
6.1
21 +0 Biogen Idec International GmbH
6.1
22 +31 Actelion Ltd.
6.1
23 +12 Cytos Biotechnology AG
6.0
24 +3 GKL Biotec AG
5.9
25 -23 Lipideon Biotechnology AG
5.9
26 +8 Nycomed Pharma AG
5.8
27 +1 BioVersys GmbH
5.8
28 +1 Auris Medical AG
5.8
29 -6 Vifor (International) Ltd.
5.7
30 +0 F. Hoffmann-La Roche AG Switzerland
5.7
31 +2 AC Immune SA
5.6
32 -7 Anavex Life Sciences Corp.
5.5
33 -7 Max Zeller Söhne AG
5.5
34 -12 Molecular Partners AG
5.4
35 +0 Novelty Pharma GDD SA
5.3
36 -5 Helvepharm AG
5.3
37 +4 Covagen AG
5.3
38 -6 Addex Pharmaceuticals
5.2
39 +11 Galenica Ltd.
5.2
40 +39 Med Discovery S.A.
5.1
41 -4 Lunamed AG
5.1
42 +0 Mundipharma Medical Company
4.9
43 -3 Permamed AG
4.9
44 -8 Axentis Pharma AG
4.8
45 -7 Novartis International AG
4.8
46 -2 Ferring International Center SA
4.7
47 -4 Ergonex Pharma GmbH
4.6
48 -9 Basilea Pharmaceutica Ltd.
4.5
49 -7 Aurora Pharma GmbH
4.4
50 +5 3-V Biosciences GmbH
4.4


Changes in rank are compared to 2010 Q2/Global Life Sciences. Since then, 6 sites entered the survey and 7 sites could not be included in the rankings (1 fewer since last time). Build your own. Report statistics.